Multiple myeloma (MM) is a systemic hematological neoplasm in which there is an abnormal proliferation of malignant monoclonal plasmocytes that release antibodies or antibody fragments, called M proteins, in excess [1,2,3,4,5]. Here, MYOM2 is linked to Miyoshi myopathy.